(Q33323274)

English

Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data

scientific article

Statements

Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data (English)
Chiaki Tanaka
Terence O'Reilly
John M Kovarik
Nicholas Shand
Katharine Hazell
Eric Raymond
Sabine Zumstein-Mecker
Christine Stephan
Marc Hattenberger
Heidi A Lane
1596-1602

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit